Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
OR | 95%CI | P value | OR | 95%CI | P value | ||
Male | 1.449 | 1.109–1.893 | 0.007 | 1.903 | 1.213–2.984 | 0.005 | |
Age | 1.007 | 0.990–1.025 | 0.402 | ||||
BMI | 1.004 | 0.960–1.050 | 0.857 | ||||
Interval† | 0.928 | 0.899–0.957 | 0.001 | 0.931 | 0.873–0.993 | 0.03 | |
0-2d | 1.602 | 1.147–2.237 | 0.008 | 2.161 | 1.094–4.270 | 0.026 | |
3-6d | 1.618 | 1.134–2.309 | 0.006 | 3.291 | 1.622–6.677 | 0.001 | |
≥7d | Reference | Reference | |||||
Contrast volume | 0.997 | 0.992–1.003 | 0.305 | ||||
Contrast volume eGFR ratio | 0.949 | 0.844–1.068 | 0.384 | ||||
Hypertension | 1.332 | 1.021–1.739 | 0.035 | 1.232 | 0.769–1.972 | 0.489 | |
DM | 1.133 | 0.809–1.587 | 0.467 | ||||
NYHA grade 3–4 | 1.044 | 0.780–1.398 | 0.770 | ||||
LVEF | 0.982 | 0.966–0.998 | 0.03 | 0.980 | 0.956–1.005 | 0.052 | |
Hemoglobin | 0.987 | 0.979–0.995 | 0.001 | 0.986 | 0.972–1.001 | 0.056 | |
Albumin | 0.938 | 0.903–0.976 | 0.001 | 0.919 | 0.869–1.023 | 0.199 | |
BUN | 0.998 | 0.967–1.030 | 0.907 | ||||
Serum creatinine | 1.001 | 0.998–1.003 | 0.642 | ||||
eGFR | 0.988 | 0.975–1.001 | 0.075 | ||||
15 ≤ eGFR < 30 ml/min/1.73m2 | 1.048 | 0.582–1.884 | 0.877 | 0.536 | |||
30 ≤ eGFR < 45 ml/min/1.73m2 | 1.448 | 1.041–2.013 | 0.028 | 0.053 | |||
45 ≤ eGFR < 60 ml/min/1.73m2 | Reference | Reference | |||||
Uric acid | 1.001 | 1.000-1.002 | 0.088 | ||||
CPB duration | 1.003 | 1.000-1.007 | 0.087 | ||||
Cross-clamp duration | 1.007 | 1.00-1.013 | 0.039 | 1.009 | 1.000-1.017 | 0.040 | |
Combined surgery | 2.749 | 1.587–4.762 | < 0.001 | 2.882 | 0.865–6.776 | 0.346 |